Bicycle Therapeutics (BCYC) Insider Trading & Ownership → The Weight Loss Pill That Could Disrupt a $32 Billion Industry (From Behind the Markets) (Ad) Free BCYC Stock Alerts $23.62 +0.54 (+2.34%) (As of 05/8/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Bicycle Therapeutics (NASDAQ:BCYC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$438,909.08 Get BCYC Insider Trade Alerts Want to know when executives and insiders are buying or selling Bicycle Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BCYC Insider Buying and Selling by Quarter Ad Behind the MarketsBREAKING – Pentagon to Spend $20 Billion on “Distributed AI”BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it.Discover the name and ticker of this $2 stock here >>> Bicycle Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/11/2024Michael Charles Ferguso HannayInsiderSell257$22.49$5,779.93 4/3/2024Kevin LeeCEOSell3,158$23.81$75,191.98 4/3/2024Michael SkynnerCTOSell955$23.81$22,738.55 4/3/2024Nicholas KeenInsiderSell790$23.81$18,809.90 4/3/2024Travis Alvin ThompsonCAOSell152$23.81$3,619.12 1/3/2024Kevin LeeCEOSell8,703$17.50$152,302.50 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/3/2024Nigel CrockettInsiderSell2,643$17.50$46,252.50 1/3/2024Travis Alvin ThompsonCAOSell604$17.50$10,570.00 10/3/2023Alistair MilnesCOOSell442$20.00$8,840.00 10/3/2023Kevin LeeCEOSell1,470$20.00$29,400.00 10/3/2023Nicholas KeenInsiderSell272$20.00$5,440.00 10/3/2023Travis Alvin ThompsonCAOSell54$20.00$1,080.00 7/3/2023Kevin LeeCEOSell1,498$25.10$37,599.80 7/3/2023Michael SkynnerCTOSell451$25.10$11,320.10 7/3/2023Nicholas KeenInsiderSell336$25.10$8,433.60 7/3/2023Travis Alvin ThompsonCAOSell61$25.10$1,531.10 (Data available from 1/1/2013 forward) BCYC Insider Trading Activity - Frequently Asked Questions Who is on Bicycle Therapeutics's Insider Roster? The list of insiders at Bicycle Therapeutics includes Alistair Milnes, Kate Bingham, Kevin Lee, Lee Kalowski, Michael Charles Ferguso Hannay, Michael Skynner, Nicholas Keen, Nigel Crockett, Pierre Legault, and Travis Alvin Thompson. Learn more on insiders at BCYC. What percentage of Bicycle Therapeutics stock is owned by insiders? 8.50% of Bicycle Therapeutics stock is owned by insiders. Learn more on BCYC's insider holdings. Which Bicycle Therapeutics insiders have been selling company stock? The following insiders have sold BCYC shares in the last 24 months: Alistair Milnes ($8,840.00), Kevin Lee ($500,223.74), Lee Kalowski ($60,681.26), Michael Charles Ferguso Hannay ($5,779.93), Michael Skynner ($43,494.82), Nicholas Keen ($39,417.59), Nigel Crockett ($98,589.56), and Travis Alvin Thompson ($16,800.22). How much insider selling is happening at Bicycle Therapeutics? Insiders have sold a total of 34,090 Bicycle Therapeutics shares in the last 24 months for a total of $773,827.12 sold. More Insider Trading Tools from MarketBeat Related Companies: Pliant Therapeutics Insider Buying Arcturus Therapeutics Insider Buying Praxis Precision Medicines Insider Buying Evolus Insider Buying Phibro Animal Health Insider Buying Ocular Therapeutix Insider Buying Aurinia Pharmaceuticals Insider Buying Disc Medicine Insider Buying Y-mAbs Therapeutics Insider Buying AnaptysBio Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:BCYC) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bicycle Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
